ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Dhansa Labs Earnings Call: Key Takeaways

Dhansa Labs (formerly Ambey Laboratories) reported strong FY26 performance with Revenue of ₹14,153.72 lakhs and PAT of ₹552.26 lakhs. The company is diversifying into Green Energy via CBG and Napier Grass projects.

Highlights
Revenue growth7.82% YoY
MarginsEBITDA margin at 8.55%; PAT margin at 3.87%.
Demand visibilityStrong domestic demand; 94.26% revenue from domestic markets.
Management confidenceHigh; focusing on diversification and sustainable growth.

Growth

Revenue grew 7.82% YoY to ₹14,153.72 lakhs; PAT increased by 15.47% YoY to ₹552.26 lakhs.

Outlook

Planned Atrazine manufacturing project target: ₹120-140 crore additional annual revenue. Commencing 15 TPD CBG project operations in FY27.

Risks

High working capital requirements impacting export market capture; exposure to hazardous products and global political/environmental disturbances.

Source

Earnings Call filed with NSE, NSE: DHANSA. Summary written with AI assistance from the document.

Read the document ↗

Dhansa Labs Ltd: key numbers

Share price
₹24.70
Market cap
₹66.45 Cr
Revenue (annual)
₹141.5 Cr
Net profit (annual)
₹5.73 Cr
P/E (TTM)
11.6×Sector 35.5×
Promoter holding
65.05%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Dhansa Labs Ltd

All →